Cargando…
Antigen-specific TIL therapy for melanoma: a flexible platform for personalized cancer immunotherapy
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990297/ http://dx.doi.org/10.1186/2051-1426-1-S1-P19 |
_version_ | 1782312257203470336 |
---|---|
author | Kelderman, Sander Heemskerk, Bianca Toebes, Mireille van Buuren, Marit van Rooij, Nienke Bies, Laura Fanchi, Lorenzo Germeroth, Lothar Kvistborg, Pia Schumacher, Ton |
author_facet | Kelderman, Sander Heemskerk, Bianca Toebes, Mireille van Buuren, Marit van Rooij, Nienke Bies, Laura Fanchi, Lorenzo Germeroth, Lothar Kvistborg, Pia Schumacher, Ton |
author_sort | Kelderman, Sander |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3990297 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39902972014-05-01 Antigen-specific TIL therapy for melanoma: a flexible platform for personalized cancer immunotherapy Kelderman, Sander Heemskerk, Bianca Toebes, Mireille van Buuren, Marit van Rooij, Nienke Bies, Laura Fanchi, Lorenzo Germeroth, Lothar Kvistborg, Pia Schumacher, Ton J Immunother Cancer Poster Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3990297/ http://dx.doi.org/10.1186/2051-1426-1-S1-P19 Text en Copyright © 2013 Kelderman et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Poster Presentation Kelderman, Sander Heemskerk, Bianca Toebes, Mireille van Buuren, Marit van Rooij, Nienke Bies, Laura Fanchi, Lorenzo Germeroth, Lothar Kvistborg, Pia Schumacher, Ton Antigen-specific TIL therapy for melanoma: a flexible platform for personalized cancer immunotherapy |
title | Antigen-specific TIL therapy for melanoma: a flexible platform for personalized cancer immunotherapy |
title_full | Antigen-specific TIL therapy for melanoma: a flexible platform for personalized cancer immunotherapy |
title_fullStr | Antigen-specific TIL therapy for melanoma: a flexible platform for personalized cancer immunotherapy |
title_full_unstemmed | Antigen-specific TIL therapy for melanoma: a flexible platform for personalized cancer immunotherapy |
title_short | Antigen-specific TIL therapy for melanoma: a flexible platform for personalized cancer immunotherapy |
title_sort | antigen-specific til therapy for melanoma: a flexible platform for personalized cancer immunotherapy |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990297/ http://dx.doi.org/10.1186/2051-1426-1-S1-P19 |
work_keys_str_mv | AT keldermansander antigenspecifictiltherapyformelanomaaflexibleplatformforpersonalizedcancerimmunotherapy AT heemskerkbianca antigenspecifictiltherapyformelanomaaflexibleplatformforpersonalizedcancerimmunotherapy AT toebesmireille antigenspecifictiltherapyformelanomaaflexibleplatformforpersonalizedcancerimmunotherapy AT vanbuurenmarit antigenspecifictiltherapyformelanomaaflexibleplatformforpersonalizedcancerimmunotherapy AT vanrooijnienke antigenspecifictiltherapyformelanomaaflexibleplatformforpersonalizedcancerimmunotherapy AT bieslaura antigenspecifictiltherapyformelanomaaflexibleplatformforpersonalizedcancerimmunotherapy AT fanchilorenzo antigenspecifictiltherapyformelanomaaflexibleplatformforpersonalizedcancerimmunotherapy AT germerothlothar antigenspecifictiltherapyformelanomaaflexibleplatformforpersonalizedcancerimmunotherapy AT kvistborgpia antigenspecifictiltherapyformelanomaaflexibleplatformforpersonalizedcancerimmunotherapy AT schumacherton antigenspecifictiltherapyformelanomaaflexibleplatformforpersonalizedcancerimmunotherapy |